X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (49) 49
infectious diseases (45) 45
humans (43) 43
male (40) 40
life sciences (37) 37
female (35) 35
hiv (33) 33
middle aged (32) 32
adult (30) 30
hiv infections - drug therapy (29) 29
immunology (23) 23
hiv infection (21) 21
human immunodeficiency virus--hiv (21) 21
microbiology (19) 19
analysis (18) 18
virology (17) 17
virus diseases (17) 17
hiv infections - virology (16) 16
viral load (16) 16
aids/hiv (14) 14
antiretroviral drugs (14) 14
antiretroviral therapy (14) 14
acquired immune deficiency syndrome--aids (13) 13
infections (13) 13
drug therapy (12) 12
health aspects (12) 12
hiv patients (12) 12
pharmacology & pharmacy (12) 12
risk factors (12) 12
treatment outcome (12) 12
aids (11) 11
care and treatment (11) 11
infection (11) 11
santé publique et épidémiologie (11) 11
anti-hiv agents - therapeutic use (10) 10
antiviral agents (10) 10
human health and pathology (10) 10
human immunodeficiency virus (10) 10
multidisciplinary sciences (10) 10
research article (10) 10
acquired immune deficiency syndrome (9) 9
hiv infections - complications (9) 9
hiv-1 - genetics (9) 9
medicine (9) 9
patients (9) 9
risk (9) 9
science (9) 9
[sdv.mhep.mi]life sciences [q-bio]/human health and pathology/infectious diseases (8) 8
[sdv.spee]life sciences [q-bio]/santé publique et épidémiologie (8) 8
cd4 antigen (8) 8
cohort (8) 8
france (8) 8
hiv infections (8) 8
hiv-1 - isolation & purification (8) 8
therapy (8) 8
antiretroviral therapy, highly active (7) 7
deoxyribonucleic acid--dna (7) 7
dna (7) 7
genotype (7) 7
hiv-1 (7) 7
hiv-1 - drug effects (7) 7
research (7) 7
tenofovir (7) 7
time factors (7) 7
young adult (7) 7
[ sdv.mhep.mi ] life sciences [q-bio]/human health and pathology/infectious diseases (6) 6
[sdv]life sciences [q-bio] (6) 6
anti-retroviral agents - therapeutic use (6) 6
antiretroviral agents (6) 6
coinfection (6) 6
dosage and administration (6) 6
drug therapy, combination (6) 6
epidemiology (6) 6
france - epidemiology (6) 6
hepatitis (6) 6
hepatitis c (6) 6
highly active antiretroviral therapy (6) 6
hiv infections - immunology (6) 6
hiv-1 - physiology (6) 6
individuals (6) 6
men (6) 6
mortality (6) 6
prevalence (6) 6
viruses (6) 6
[ sdv.imm ] life sciences [q-bio]/immunology (5) 5
cd4 lymphocyte count (5) 5
coinfection - drug therapy (5) 5
deoxyribonucleic acid (5) 5
emtricitabine (5) 5
hepatitis c virus (5) 5
hepatitis c, chronic - drug therapy (5) 5
hiv infections - epidemiology (5) 5
hiv-infected patients (5) 5
human-immunodeficiency-virus (5) 5
medical research (5) 5
medicine, general & internal (5) 5
microbiology and parasitology (5) 5
pharmacology (5) 5
population (5) 5
retrospective studies (5) 5
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 02/2017, Volume 12, Issue 2, p. e0170661
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2015, Volume 373, Issue 23, pp. 2237 - 2246
Journal Article
BMC Infectious Diseases, ISSN 1471-2334, 07/2016, Volume 16, Issue 1, p. 345
Journal Article
Virologie (Montrouge, France), ISSN 1267-8694, 08/2019, Volume 23, Issue 4, p. 250
The establishment of latent infection in long-lived cells is the main obstacle to HIV cure or sustained remission without antiretroviral therapy. The most... 
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2015, Volume 10, Issue 10, p. e0141164
Objectives Development of direct acting antivirals (DAA) offers new benefits for patients with chronic hepatitis C. The combination of these drugs with... 
GENOTYPE 1 | THERAPY | TELAPREVIR | HEPATITIS-C VIRUS | SOFOSBUVIR PLUS RIBAVIRIN | MULTIDISCIPLINARY SCIENCES | OPEN-LABEL | NATURAL-HISTORY | HIV-INFECTED PATIENTS | Hepacivirus - drug effects | Cross-Sectional Studies | Coinfection - drug therapy | Humans | Middle Aged | Male | Hepatitis C, Chronic - drug therapy | Drug Therapy, Combination - adverse effects | Hepatitis C Antibodies | Drug Interactions - physiology | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | Protease Inhibitors - therapeutic use | Highly active antiretroviral therapy | Comorbidity | Drug interactions | Patient outcomes | Observations | Hepatitis C | Drug therapy | HIV infection | Drugs | RNA-directed DNA polymerase | Antibodies | Systematic review | Infections | Ribavirin | Hepatitis | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | Nucleoside reverse transcriptase inhibitors | Human immunodeficiency virus--HIV | Integrase | Antiviral agents | Liver diseases | Hematology | Proteinase inhibitors | Ribonucleic acid--RNA | Patients | Non-nucleoside reverse transcriptase inhibitors | Protease inhibitors | Biopsy | Response rates | Nucleosides | Interferon | Hepatitis C virus | Life Sciences | Human health and pathology | Pharmacology | Infectious diseases | Pharmaceutical sciences | RNA | Acquired immune deficiency syndrome | Ribonucleic acid | AIDS | HIV | Human immunodeficiency virus
Journal Article
by Virlogeux, Victor and Zoulim, Fabien and Pugliese, Pascal and Poizot-Martin, Isabelle and Valantin, Marc-Antoine and Cuzin, Lise and Reynes, Jacques and Billaud, Eric and Huleux, Thomas and Bani-Sadr, Firouze and Rey, David and Frésard, Anne and Jacomet, Christine and Duvivier, Claudine and Cheret, Antoine and Hustache-Mathieu, Laurent and Hoen, Bruno and Cabié, André and Cotte, Laurent and Chidiac, C and Ferry, T and Ader, F and Biron, F and Boibieux, A and Miailhes, P and Perpoint, T and Schlienger, I and Lippmann, J and Braun, E and Koffi, J and Longuet, C and Guéripel, V and Augustin-Normand, C and Brochier, C and Degroodt, S and Pugliese, Pascal and Ceppi, C and Cua, E and Cottalorda, J and Courjon, J and Dellamonica, P and Demonchy, E and De Monte, A and Durant, J and Etienne, C and Ferrando, S and Fuzibet, J.G and Garraffo, R and Joulie, A and Risso, K and Mondain, V and Naqvi, A and Oran, N and Perbost, I and Pillet, S and Prouvost-Keller, B and Wehrlen-Pugliese, S and Rosenthal, E and Sausse, S and Rio, V and Roger, P.M and Brégigeon, S and Faucher, O and Obry-Roguet, V and Orticoni, M and Soavi, M.J and de Lamarlière, P. Geneau and Laroche, H and Ressiot, E and Carta, M and Ducassou, M.J and Jacquet, I and Gallie, S and Galinier, A and Ritleng, A.S and Ivanova, A and Blanco-Betancourt, C and Lions, C and Debreux, C and Obry-Roguet, V and Agher, R and Katlama, C and Lortholary, O and Lanternier, F and Charlier, C and Rouzaud, C and Aguilar, C and Henry, B and Lebeaux, D and Cessot, G and Gergely, A and Consigny, P.H and Touam, F and Louisin, C and Alvarez, M and Biezunski, N and Debard, A and Delobel, P and Delpierre, C and Fourcade, C and ... and Dat'AIDS Study Grp and Dat’AIDS Study Group and the Dat’AIDS Study Group
BMC Medicine, ISSN 1741-7015, 12/2017, Volume 15, Issue 1, pp. 217 - 11
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2015, Volume 15, Issue 4, pp. 387 - 396
Journal Article
Journal Article